Recent announcement from the AAEP:

“As you may be aware, the FDA has withdrawn the drug pergolide from the market for use in humans. In order for the drug to continue to be available for use in veterinary medicine, the FDA must approve an exception for pergolide to be used by veterinarians and to be compounded in bulk quantities.

The AAEP, through its Drug Compounding Task Force, has been in contact with the FDA, and they are aware of the significant impact of pergolide’’s withdrawal from the market on equine medicine. The FDA Center for Veterinary Medicine is working with its counterpart for human medicine, the Center for Drug Evaluation and Research, to allow importation of pergolide for use by compounding pharmacies. The FDA expects to have an official announcement by the end of this week.

The AAEP will continue to communicate with the FDA on this issue. For updates, please visit the AAEP Web site.

Sincerely,
The AAEP”

Article from thehorse.com: Pergolide: Veterinarians, Horse Owners Fighting for Availability

Another article from thehorse.com providing background on the issue: Equine Cushing’s Drug Pergolide to be Withdrawn for Human Use